Notice Regarding Borrowing of Funds (Refinance)

Purpose and Overview of Refinancing

PeptiDream Inc. entered into a syndicated loan agreement arranged by Mizuho Bank, Ltd. on March 16, 2026, for the purpose of refinancing funds related to the radiopharmaceutical business acquired from FUJIFILM Toyama Chemical Co., Ltd. on March 28, 2022. The loan amount is 16.44 billion yen, with a loan term of 7.5 years and a loan execution date of March 31, 2026. This refinancing will be applied to repay existing borrowings, aiming to reduce interest expenses and stabilize the financial base.

Future Outlook and Impact

This refinancing has already been factored into the earnings guidance for the fiscal year ending December 2026 announced on February 16, 2026, and there is no change to the earnings forecast. Although there was a breach of financial covenants under syndicated loan agreements with multiple financial institutions, it has been determined that no significant uncertainties remain due to the conclusion of this agreement.